Articles by Philip Ward - Applied Clinical Trials


Articles by Philip Ward

Philip Ward

Philip Ward is ACT's European editor, phone +44 1244 538583,

EMA Provides Rapid Feedback on GSK Ebola Vaccine
October 30, 2014

European Medicines Agency has given 'rapid scientific advice'

EUPATI's New Training Course for Patients Gets Underway
October 29, 2014

The first patient expert training course of the European Patients' Academy (EUPATI) has begun.

Were Clinical Trial Practices in East Germany Questionable?
October 24, 2014

Pharmaceutical companies took advantage of East Germany's financial problems, report found.

UK Clinical Research Infrastructure Initiative Gets Boost
October 23, 2014

The Clinical Research Infrastructure Initiative will benefit from additional funding from the UK government

Finding Ebola Treatments Requires Partnerships
October 16, 2014

In the battle against Ebola, incentives from governments and healthcare policymakers have been and will continue to be vital...

Gustave Roussy in Paris Links Up with New Oncology
October 14, 2014

New Oncology has entered into a research agreement with Gustave Roussy Cancer Campus in Paris.

Debate Intensifies on Trial Design for Ebola Treatments
October 13, 2014

Experts have supported the deployment of alternative trial designs to fast-track the evaluation of new Ebola treatments.

EMA Unveils New Data in Mid-year Report
October 9, 2014

During the first six months of 2014, the number of scientific advice and protocol assistance requests for human medicines received by the EMA increased by 16%

ACRES Opens New Branch in Japan
October 7, 2014

The Alliance for Clinical Research Excellence and Safety (ACRES) has opened its first national affiliate, ACRES Japan, in Tokyo. Fumimaro Takaku, M.D., president of the Japanese Association of Medical Sciences, will act as president of the board of directors, and ACRES Japan will provide a model for the organization?s planned network of national affiliates.



Untitled Document
Click here